{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T07:29:23Z","timestamp":1665127763795},"reference-count":20,"publisher":"The Japan Geriatrics Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nippon Ronen Igakkai Zasshi","Nihon Ronen Igakkai Zasshi","Jpn J Geriat","Jpn. j. geriat"],"published-print":{"date-parts":[[2022,4,25]]},"DOI":"10.3143\/geriatrics.59.244","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T22:12:20Z","timestamp":1654121540000},"page":"244-248","source":"Crossref","is-referenced-by-count":1,"title":["A patient with rheumatoid arthritis who developed liver cirrhosis after increased soft drinks intake"],"prefix":"10.3143","volume":"59","author":[{"given":"Nobuyuki","family":"Yamashita","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Shin-Kokura Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yugo","family":"Miyagi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Shin-Kokura Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Maekawa","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Shin-Kokura Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Tsukamoto","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Shin-Kokura Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1704","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1) \u9ed2\u7530 \u6bc5, \u9577\u8c37\u5ddd\u7d75\u91cc\u5b50, \u82e5\u677e\u5f69\u5b50, \u4f50\u85e4\u5f18\u6075, \u5c0f\u6797\u5927\u4ecb, \u4e2d\u679d\u6b66\u53f8\u307b\u304b: \u9ad8\u9f62\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u60a3\u8005\u306e\u81e8\u5e8a\u7684\u691c\u8a0e. \u81e8\u5e8a\u30ea\u30a6\u30de\u30c1 2021; 33: 106-112.","DOI":"10.14961\/cra.33.106"},{"key":"2","unstructured":"2) \u65e5\u672c\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a: \u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u8a3a\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f32020, \u8a3a\u65ad\u3068\u6cbb\u7642\u793e, \u6771\u4eac, 2021."},{"key":"3","unstructured":"3) \u65e5\u672c\u6d88\u5316\u5668\u75c5\u5b66\u4f1a, \u65e5\u672c\u809d\u81d3\u5b66\u4f1a: NAFLD\/NASH\u8a3a\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f32020 (\u6539\u8a02\u7b2c2\u7248), \u5357\u6c5f\u5802, \u6771\u4eac, 2020."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Hashimoto E, Tokushige K: Prevalence, gender, ethnic variations, and prognosis of NASH. J Gastroenterol 2011; 46 (Suppl 1): 63-69.","DOI":"10.1007\/s00535-010-0311-8"},{"key":"5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.taap.2015.08.022","volume":"289","author":"JD Schumacher","year":"2015","unstructured":"5) Schumacher JD, Guo GL: Mechanistic review of drug-induced steatohepatitis. Toxicology and applied pharmacology 2015; 289: 40-47.","journal-title":"Toxicology and Applied Pharmacology","ISSN":"http:\/\/id.crossref.org\/issn\/0041-008X","issn-type":"print"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6) Kremer JM, Lee JK: The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis. Arthritis and rheumatism 1986; 29: 822-831.","DOI":"10.1002\/art.1780290702"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7) Walker AM, Funch D, Dreyer NA, Tolman KG, Kremer JM, Alarc\u00f3n GS, et al.: Determinants of serious liver disease among patients receiving low-dose methotrexate for rheumatoid arthritis. Arthritis and rheumatism 1993; 36: 329-335.","DOI":"10.1002\/art.1780360307"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8) \u4eca\u5c3e\u6cf0\u4e4b, \u4f50\u85e4\u60a6\u4e45, \u5ddd\u6751\u76f4\u5f18, \u6d45\u8449\u5ba3\u4e4b, \u6839\u6d25\u4f50\u6c5f\u5b50, \u5c71\u53e3\u5eb7\u6674\u307b\u304b: \u6295\u4e0e\u4e2d\u6b62\u306b\u3088\u308a\u9580\u8108\u5727\u4ea2\u9032\u6240\u898b\u304c\u6539\u5584\u3057\u305f\u30e1\u30c8\u30c8\u30ec\u30ad\u30b5\u30fc\u30c8\u306b\u3088\u308b\u809d\u7dda\u7dad\u75c7\u306e1\u4f8b. \u809d\u81d3 2003; 44: 586-592.","DOI":"10.2957\/kanzo.44.586"},{"key":"9","unstructured":"9) \u6fa4\u7530\u4fdd\u5f66, \u829d\u672c\u5f70\u5f66, \u74e6\u8c37\u82f1\u4eba, \u5409\u6cbb\u4ec1\u5fd7: \u85ac\u7269\u6027\u809d\u969c\u5bb3\u306b\u3088\u308a\u8179\u6c34\u8caf\u7559\u3092\u304d\u305f\u3057\u305f1\u4f8b. \u81e8\u5e8a\u6d88\u5316\u5668\u5185\u79d1 2021; 36: 103-108."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Eguchi Y, Hyogo H, Ono M, Mizuta T, Ono N, Fujimoto K, et al.: Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study. J Gastroenterol 2012; 47: 586-595.","DOI":"10.1007\/s00535-012-0533-z"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Nakahara T, Hyogo H, Yoneda M, Sumida Y, Eguchi Y, Fujii H, et al.: Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients. J Gastroenterol 2014; 49: 1477-1484.","DOI":"10.1007\/s00535-013-0911-1"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Dawwas MF, Aithal GP: End-stage methotrexate-related liver disease is rare and associated with features of the metabolic syndrome. Alimentary pharmacology &amp; therapeutics 2014; 40: 938-948.","DOI":"10.1111\/apt.12912"},{"key":"13","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.amjms.2017.03.014","volume":"354","author":"A Shetty","year":"2017","unstructured":"13) Shetty A, Cho W, Alazawi W, Syn WK: Methotrexate Hepatotoxicity and the Impact of Nonalcoholic Fatty Liver Disease. The American journal of the medical sciences 2017; 354: 172-181.","journal-title":"The American Journal of the Medical Sciences","ISSN":"http:\/\/id.crossref.org\/issn\/0002-9629","issn-type":"print"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14) Mofrad P, Contos MJ, Haque M, Sargeant C, Fisher RA, Luketic VA, et al.: Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 2003; 37: 1286-1292.","DOI":"10.1053\/jhep.2003.50229"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15) Sumida Y, Yoneda M, Hyogo H, Itoh Y, Ono M, Fujii H, et al.: Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population. BMC gastroenterology 2012; 12: 2.","DOI":"10.1186\/1471-230X-12-2"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16) Wynne HA, Cope LH, Mutch E, Rawlins MD, Woodhouse KW, James OF: The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology 1989; 9: 297-301.","DOI":"10.1002\/hep.1840090222"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Molina DK, DiMaio VJ: Normal Organ Weights in Women: Part II-The Brain, Lungs, Liver, Spleen, and Kidneys. Am J Forensic Med Pathol 2015; 36: 182-187.","DOI":"10.1097\/PAF.0000000000000175"},{"key":"18","unstructured":"18) \u65e5\u672c\u6551\u6025\u533b\u5b66\u4f1a: \u71b1\u4e2d\u75c7\u8a3a\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f32015. https:\/\/www.jaam.jp\/info\/2015\/pdf\/info-20150413.pdf (accessed 2021-12-2)."},{"key":"19","doi-asserted-by":"publisher","unstructured":"19) \u7530\u4e2d \u8302: \u7dcf\u8ad6 \u30a8\u30cd\u30eb\u30ae\u30fc\u6d88\u8cbb\u91cf\u3068\u305d\u306e\u6e2c\u5b9a\u65b9\u6cd5. \u9759\u8108\u7d4c\u8178\u6804\u990a 2009; 24: 1013-1019.","DOI":"10.11244\/jjspen.24.1013"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Ouyang X, Cirillo P, Sautin Y, McCall S, Bruchette JL, Diehl AM, et al.: Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol 2008; 48: 993-999.","DOI":"10.1016\/j.jhep.2008.02.011"}],"container-title":["Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/geriatrics\/59\/2\/59_59.244\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T04:47:53Z","timestamp":1654318073000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/geriatrics\/59\/2\/59_59.244\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,25]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.3143\/geriatrics.59.244","relation":{},"ISSN":["0300-9173"],"issn-type":[{"value":"0300-9173","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,25]]},"article-number":"59.244"}}